Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bapat BV, Parker JA, Berk T et al (1994) Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines. Dis Colon Rectum 37(2):165–171
Sporn MB (1976) Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 36:2699–2702
Gann PH, Manson JE, Glynn RJ et al (1993) Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85:1220–1224
Baron JA, Cole BF, Sandler RS et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891–899
Sandler RS, Halabi S, Baron JA et al (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348:883–890
Ruschoff J, Wallinger S, Dietmaier W et al (1998) Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci USA 95:11301–11306
Giardiello FM, Hamilton SR, Krush AJ et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313–1316
Steinbach G, Lynch PM, Phillips RKS et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952
Narisawa T, Fukaura Y, Terada K, Sekiguchi H (1998) Prevention of N-methylnitrosourea-induced colon tumorigenesis by ursodeoxycholic acid in F344 rats. Jpn J Cancer Res 89:1009–1013
Rodrigues CM, Kren BT, Steer CJ, Setchell KD (1995) The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation. Gastroenterology 109:1835–1844
Ikegami T, Matsuzaki Y, Shoda J et al (1998) The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A2 expression in colonic tissue. Cancer Lett 134:129–139
Davignon J, Laaksonen R (1999) Low-density lipoprotein-independent effects of statins. Curr Opin Lipidol 10:543–559
Torrance CJ, Jackson PE, Montgomery E et al (2000) Combinatorial chemoprevention of intestinal neoplasia. Nat Med 6:1024–1028
Clapper ML, Chang WC, Meropol NJ (2001) Chemoprevention of colorectal cancer. Curr Opin Oncol 13:307–313
Winde G, Schmid KW, Schlegel W, Fischer R, Osswald H, Bunte H (2005) Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment: advantages of a lowdose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months. Am J Gastroenterol 100(7):1498–1502
de Vos tot Nederveen Cappel WH, Jarvinen HJ, Bjork J et al (2003) Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis. Br J Surg 90(6):705–710
Tulchinsky H, Keidar A, Goldman G et al (2005) Surgical treatment and long-term outcome of patients with familial adenomatous polyposis: 16 years experience at the Tel Aviv Sourasky Medical Center. Isr Med Assoc J 7(2):82–85
Lee J, Hargest R, Wasan H, Phillips RKS (2004) Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model. Dis Colon Rectum 47(12):2105–2113
Bright-Thomas RM, Agrawal A, Hargest R (2002) Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis. Br J Surg 89(12):1563–1569
Burke CA, Santisi J, Church J, Levinthal G (2005) The utility of capsule endoscopy small bowel surveillance in patients with polyposis. Am J Gastroenterol 100(7):1498–1502
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
Delaini, G.G., Scaglia, M., Colucci, G., Öresland, T. (2006). Emergent Issues and Future Trends in Familial Adenomatous Polyposis. In: Delaini, G.G. (eds) Inflammatory Bowel Disease and Familial Adenomatous Polyposis. Springer, Milano. https://doi.org/10.1007/88-470-0434-9_34
Download citation
DOI: https://doi.org/10.1007/88-470-0434-9_34
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0433-7
Online ISBN: 978-88-470-0434-4
eBook Packages: MedicineMedicine (R0)